Chinese expert consensus on clinical application of molecularly targeted drugs for hepatocellular carcinoma (2022 edition)

• Juxian Sun,
• Qiu Li,
• Xueli Bai,
• Jianqiang Cai,
• Yajin Chen,
• Minshan Chen,
• Chaoliu Dai,
• Chihua Fang,
• Weidong Jia,
• Xiangcheng Li,
• Tianfu Wen,
• Jinglin Xia,
• Mingang Ying,
• Zhiwei Zhang,
• Xuewen Zhang,
• Zhaochong Zeng,
• Shuqun Cheng,
• On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association,
• Sihan Zhou,
• Xiuyuan Hao

Affiliations

Juxian Sun

1 Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, China

Qiu Li

2 Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

Xueli Bai

3 Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China

Jianqiang Cai

4 Department of Hepatobiliary Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China

Yajin Chen

5 Department of Hepatobiliopancreatic Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong 510120, China

Minshan Chen

6 Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510050, China

Chaoliu Dai

7 Department of Hepatobiliary and Spleenary Surgery, The Affiliated Shengjing Hospital, China Medical University, Shenyang, Liaoning 110022, China

Chihua Fang

8 Department of Hepatobiliary Surgery, Zhujiang Hospital, First Military Medical University, Guangzhou, Guangdong 510280, China

Weidong Jia

9 Department of General Surgery, Anhui Key Laboratory of Hepatopancreatobiliary Surgery, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui 230031, China

Xiangcheng Li

10 Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Liver Transplantation, Nanjing, Jiangsu 210029, China

Tianfu Wen

11 Department of Liver Surgery, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China

Jinglin Xia

12 The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China

Mingang Ying

14 Department of Gastrointestinal Oncological Surgery, Fujian Provincial Cancer Hospital, Fujian Medical University Teaching Hospital, Fuzhou, Fujian 350014, China

Zhiwei Zhang

15 Department of Surgery, Hepatic Surgery Center, Institute of HBP Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China

Xuewen Zhang

16 Department of Hepatobiliary and Pancreas Surgery, The Second Hospital of Jilin University, Changchun, Jilin 130041, China

Zhaochong Zeng

17 Department of Radiation Oncology, Zhongshan Hospital, Fudan University, Shanghai 200030, China

Shuqun Cheng

1 Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai 200438, China

On behalf of Chinese Association of Liver Cancer and Chinese Medical Doctor Association

Sihan Zhou

Xiuyuan Hao